07 Jan 2001

Cefavora® (Cefavora® Tropfen) - Deutschland

Cefavora® Description, Presentation and Dosage

Cefavora® Description

Cefavora® Drug Class Description


Cefavora® Drug Description

100 g enth.: Ginkgo biloba 'Urtink.' 1,3 g, Viscum album 'Urtink.' 2,7 g, Crataegus 'Urtink.' 7,5 g.

Cefavora® Generic Name

Cefavora® Tropfen

Cefavora® Presentation

Cefavora® Presentation


Cefavora® Manufacturer


Related Learning Zones

Heart Failure

Heart Failure is a progressive chronic disorder that results in the inability of the heart to pump blood efficiently to the bodys tissues.

Chronic heart failure is an increasing public health problem; the growing prevalence in industrialised countries means that 1-2% of the adult population of these countries are now thought to have chronic heart failure.1-3 Estimates suggest that the prevalence in Europe, USA and Japan could increase by approximately 16.5% over the next ten years.4



The Hypogonadism Knowledge Centre gives healthcare professionals free access to resources on the diagnosis, treatment and monitoring of patients with the condition. The regularly-updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

Cefavora® Dosage

Cefavora® Adult Dosage


Cefavora® Precautions, Reactions and Contraindications

Cefavora® Special Precautions

Related Drugs - Angiology

Back to top